company? Let’s change
that.
Don't see your company?
Create a company profileBioSymetrics is an AI-powered drug discovery company.
BRC is a pharmaceutical manufacturing and development firm focused on the production of DEA approved cannabinoid API and botanically derived therapeutics. Our mission is to provide federally compliant, active pharmaceutical ingredients and plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere.
IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve operations. Headquartered in Pennsylvania, IPS is a multinational company with over 1,800 professionals and 23 offices in 10 countries in the United States, Canada, Brazil, the United Kingdom, Ireland, Germany, Switzerland, Singapore, China, and India. With the newest acquisition of Linesight, IPS has over 3,000 professionals in 45+ offices across 17 countries in the Americas, Europe, Asia Pacific, Southeast Asia, Australia, and the Middle East. Linesight specializes in cost, schedule, risk, program, and project management services in various market sectors, including data centers, life sciences, and high-tech industrial.
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates.
Med Communications is dedicated to delivering high-quality medical affairs, pharmacovigilance, and commercial solutions
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.
Anaphore is developing protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. RuiYi is a Wholly Foreign-Owned Enterprise (WFOE) located in the Zhangjiang Hi-Tech Park in Pudong Shanghai, China. RuiYi is developing biologic therapies that target G protein coupled receptors (GPCRs).
Outplay, Inc. is a science-driven, biotechnology company.
Polaris Pharmacy Services is the leading provider of long-term care pharmacy solutions serving multiple locations across the eastern United States. We at Polaris are committed to exceptional service and excellent value and we count on different programs that can help meet your needs. Our technology based solutions include, enhanced clinical services, client web portal, web-based discharge program, HIPAA compliant communication, ePrescribing, and a myriad of education options to help your facility stay compliant. Our caring approach has been built on years of long-term care experience and we know that through service and dedication to our clients we can provide the quality and care that you deserve.
Enriching Lives Through Personalized Medicine and Care Doing the right thing... in the right way... at the right time... in the right place... for the right person... with the right feeling... the first time. Akina Specialty Compounding Pharmacy is purpose driven to provide healthcare providers and their patients with the most meticulously sterile and non-sterile compounded medications and exceptional service.
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at very small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) and generic peptide APIs under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes. Ambio is a drug development company with a rich and growing pipeline of proprietary drug development programs for bioequivalent and biosimilar versions of the world’s best-selling peptide drugs. Ambio Pharmaceuticals is the parent company of AmbioPharm, Inc. and Ambio, Inc.
Eye-Pharma, LLC is an ophthalmic drug company that is pioneering new brand and generic drug products.
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
TheraTarget is led by world-renown experts in polymer-drug chemistry.
Ceregene is a biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Headquartered in Dedham, Mass., AliMed is a specialty medical supplies manufacturer and distributor with on-site customization capabilities and a vast portfolio of healthcare products designed to improve patient outcomes and experiences. Celebrating 50 years of serving patient needs spanning “hospital to home,” AliMed has built its long history and strong reputation on responsiveness, exceptional customer service, and high-quality offerings. Visit AliMed.com for more information. Rehabilitation • Orthopedics • Skilled Nursing • Operating Room • Medical Imaging
Tandem Labs is a leading bioanalytical Contract Research Organization (CRO) specializing in advanced mass spectrometry.
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.